C-SATS Announces Limeade CEO Henry Albrecht Has Joined Its Board of Directors
(Press release by C-SATS originally appeared in PRWeb)
Seattle, Wash., January 19, 2016 –– C-SATS, a venture-backed healthcare technology company on a mission to empower the nation’s healthcare institutions so they can assess and improve the performance of their surgeons and other professionals continuously, accurately and objectively, today announced that Henry Albrecht, CEO of Limeade, has joined its Board of Directors.
A well-known healthcare speaker, innovator and disruptor, Albrecht founded Limeade – a corporate wellness technology company that measurably improves employee health, well-being and performance while building cultures that support well-being – in 2006. Since then, Limeade has become one of the fastest growing technology companies in North America.
“Henry brings a unique set of skills to our board,” explains Derek Streat, CEO of C-SATS. “He’s operationally savvy, culture-focused and entrepreneurial. Limeade is the kind of company that we’d like C-SATS to ultimately become, and its track record in terms of selling into the enterprise, enriching health and fitness and building relationships with hospital clients is just tremendous. We’re fortunate to have Henry’s experience, wisdom and counsel at C-SATS.”
Albrecht joins Streat, Thomas Lendvay MD, C-SATS’ Chief Medical Officer, and Hans Lundin, CFO at Point B Capital, on the C-SATS board.
Before launching Limeade, Albrecht was Vice President of Product Management at enterprise software company Bocada, and a product, brand and business manager at financial software company Intuit.
Albrecht earned his MBA from Northwestern’s Kellogg School of Management with an emphasis in technology and marketing and his BA with honors from Claremont McKenna College.
“I’m convinced that C-SATS is going to change the way that the healthcare industry operates in the 21st century,” says Albrecht. “The current state of technical skills assessment in medicine is prohibitively expensive, time-intensive and subjective. C-SATS’ scalable software uses a unique combination of experts and reviewers to assess technical performance with gold standard accuracy. That’s a critical and necessary breakthrough.”
Seattle-based C-SATS, Inc. is a venture-backed healthcare technology company on a mission to empower the nation’s healthcare institutions so they can assess and improve the performance of their surgeons and other professionals continuously, accurately and objectively. Based on technology developed at the University of Washington by a team of surgeons, biostatisticians and engineers, C-SATS’ performance management system utilizes a unique combination of distributed experts and pre-qualified reviewers to assess surgical skill. After benchmarking a team and identifying the gaps in performance, C-SATS recommends targeted curriculum to help teams improve and track their performance improvement longitudinally. Medical centers across the U.S. and Canada have completed over 750,000 assessments via C-SATS for a variety of uses, including credentialing and privileging, residency and training, and continuous quality improvement.
Limeade released new employment data demonstrating concentrated focus on increasing gender representation across its global workforce. As of February 2022, Limeade reported 51% women make up the employee population and 48% of director-level and above leadership roles are held by women.